return to news
  1. Sterlite Tech, Aditya Infotech, Park Medi World, HFCL among top 10 stocks with 100%+ returns in 2026

Market News

Sterlite Tech, Aditya Infotech, Park Medi World, HFCL among top 10 stocks with 100%+ returns in 2026

SUMMARY

NIFTY50 and SENSEX underperformed in the first half of 2026 as US trade tariffs, Middle East conflict, FIIs sell-off and crude price rise impacted the market sentiments. Despite weak market performance, several midcap stocks like Sterlite Technologies, Garware Hi-Tech, Rubicon Research, Mtar Technologies and others delivered returns of 100% and more to investors.

Sterlite_Tech_share_rise

Telecom infrastructure stocks Sterlite Technologies and HFCL outperform amid rising demand from AI infrastructure and data centres.

NIFTY50, SENSEX and the overall Indian stock market performance in the first half of 2026 were heavily dictated by multiple events. NIFTY50 and SENSEX are down 8.6% and 10.2% as of June 30, 2026, amid several global and domestic headwinds.

Open FREE Demat Account within minutes!
Join now

The first half of 2026 saw US trade tariffs that disrupted the global supply chain, followed by the US-Israel-Iran war. Military action in the Middle East region impacted the crude oil supplies. As a result, crude oil prices surged to record high levels. Meanwhile, AI and AI-related stocks grab investors' attention, especially in the US and South Korean markets, despite several headwinds.

In the domestic markets, record FIIs sell-off, decline in traditional IT stocks due to AI demand, rupee depreciation and crude oil spike made investors' sentiments weak.

Despite these headwinds, some of the stocks went against the tide and delivered strong returns to their investors.

Here is a list of 10 stocks which delivered a return of 100% and above in the first half of 2026:
StockIndustryMarket capYTD return*
Sterlite TechnologiesTelecom equipment₹29,829 crore494%
Mtar TechnologiesPrecision engineering₹23,404 crore215%
HFCL LimitedTelecom equipment₹32,617 crore214%
Aditya InfotechElectronic video surveillance₹43,242 crore144%
Garware Hi-TechSpeciality protection films₹15,528 crore114%
Acutaas ChemicalsSpecialty chemicals₹28,908 crore106%
Atlanta ElectricalsElectrical equipments₹13,943 crore106%
Rubicon ResearchPharmaceutical₹23,123 crore105%
Avalon TechnologiesElectronic manufacturing₹12,044 crore105%
Park Medi WorldMultispecialty hospitals₹12,977 crore104%
*YTD return as per the market closing price on NSE. Stocks with a market cap of ₹10,000 crore and above are considered

Key notes

  • The table above highlights the best-performing stocks in the first half of 2026. These stocks belong to different industries and are not concentrated in a single sector.
  • Most of the top-performing companies are mid-cap businesses benefiting from strong earnings growth and sector-specific tailwinds.
  • The sharp surge in stock price indicates that the investors are willing to assign premium valuations to companies demonstrating sustained growth visibility and execution.
  • Another key observation is that most of these companies belong to sunrise industries like AI infrastructure, precision engineering, electronics, speciality chemicals and healthcare.

Telecom infrastructure stocks outperformance

Sterlite Technologies and HFCL emerged as the top-performing stocks in the first half of 2026, with returns of 494% and 214% supported by strong industry tailwinds and company-specific growth. Rising investment in AI infrastructure and data centres in India increased demand for fibre-optic cables and high-speed connectivity solutions offered by these companies. Besides this, the 5G network rollout in India increased orders for telecom equipment and optical fibre products.

Both companies reported strong order books and improved financial performance. In FY26, Sterlite Technologies' consolidated revenue rose 18.8% YoY to ₹4,745 crore, while the company turned profitable with net profit after tax of ₹56 crore compared to a loss of ₹123 crore in FY25. Meanwhile, HFCL reported consolidated revenue of ₹4,949 crore (up 21.7% YoY) and a net profit of ₹329 crore (90.1% YoY).

Mtar Technologies delivers a strong return

MTAR Technologies shares delivered a 215% return to its investors so far in 2026. The company benefited from robust demand from the aerospace, defence, clean energy and nuclear sectors. Investors rewarded the company for its healthy order book and long-term growth visibility. Rising investments by the government in energy transition projects like hydrogen and nuclear power are positive for the company as it manufactures several equipment related to clean energy.

In FY26, the company reported consolidated revenue from operations of ₹876 crore, up 29.5% YoY, while net profit jumped 75.9% YoY to ₹95 crore.

Electronics manufacturing became a major theme

Electronic segment companies Aditya Infotech and Avalon Technologies delivered YTD returns of 144% and 105%. Rising demand for surveillance systems and smart security solutions boosted the order book and business of Aditya Infotech, which operates the flagship brand CP PLUS. Avalon Technologies gained from growing orders for electronic manufacturing services (EMS) and the push for domestic manufacturing through schemes like Make in India and Production Linked Incentive (PLI).

In FY26, Aditya Infotech reported robust financial performance, with total revenue rising 35.6% YoY to ₹4,221 crore, while its net profit stood at ₹368 crore, up 4.8% YoY. Meanwhile, Avalon Technologies reported consolidated revenue of ₹1,603 crore (up 45.9% YoY) and a net profit of ₹113 crore, up 79.3% YoY.

Pharma and healthcare stocks attract investors

Pharma company Rubicon Research and Hospital chain operator Park Medi World delivered 105% and 104% returns to investors in the first six months of 2026. Park Medi World stock gained supported by robust FY26 earnings and expansion of its hospital network. In May 2026, the company successfully acquired a 100% stake in The Medicity Hospital in Rudrapur for ₹177 crore, expanding its footprint to 17 hospitals. In FY26, Park Medi World's revenue rose 20.4% YoY to ₹1,679 crore, while net profit jumped 28.6% YoY to ₹274 crore.

Rubicon Research stock benefited from rising demand for generic medicines in regulated markets such as the US and Europe. The pharma company also posted robust FY26 earnings with its profit after tax (PAT) rising 84.3% YoY to ₹247 crore, while revenue from operations rose 36.6% YoY to ₹1,754 crore.

Speciality manufacturing stocks surge in 2026

Garware Hi-Tech and Acutaas Chemicals delivered 114% and 106% returns so far in 2026 due to favourable industry trends and rising demand for speciality products, which offer higher profit margins than commodity products. Besides this strong export demand, rising sales and improved margins also supported the stock performance.


Disclaimer:

The stock discussed in this article is only for educational purposes and not a buy or sell recommendation. Investors are advised to conduct their own analysis and risk due diligence before trading and investing in the stock market. Investments in the securities market are subject to market risk. Read all the related documents carefully before investing.

About The Author

Upstox logo
Sreenivas Ajankar is a Deputy Editor at Upstox and has over nine years of experience in capital markets. His areas of expertise include equity research, analysis and business valuation.

Next Story